Onchilles Pharma Presents at AACR 2024 New Preclinical Data for N17350 and N17465 Demonstrating the Potential for Potent and Tumor-Selective Treatment
SAN DIEGO--(BUSINESS WIRE)--Apr 9, 2024--
Source: eagletribune.com
📰 Lev Becker News
Lev Becker News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lev Becker. Real-time updates on events, politics, business and more.
Onchilles Pharma Announces Presentation of Data for N17350 Program at SITC 2023
Onchilles Pharma, a private biotech company developing new pan-cancer therapeutics that leverage a novel mechanism of action, announced today the presentation of preclinical data for the N17350 program at the Society for Immunotherapy of Cancer...
Lev Becker Onchilles Pharma San Diego Convention Center Onchille Co Society For Immunotherapy Of Cancer Pharma Announces Presentation
Source: lelezard.com
Major anti-cancer protein released by neutrophils selectively kills tumor cells
A study published in the June 10, 2021 issue of Cell describes a remarkable new mechanism by which the body's own immune system can eliminate cancer cells without damaging host cells.
Onchilles Pharma Lev Becker Emily Henderson Ben May Department For Cancer Research University Of Chicago Medicine Comprehensive Cancer Center Uchicago Medicine Comprehensive Cancer Center
Source: news-medical.net
Could neutrophils be the secret to cancer's Achilles' heel?
A study published in the June 10, 2021 issue of Cell describes a remarkable new mechanism by which the bodys own immune system can eliminate cancer cells without damaging host cells. The findings have the potential to develop first-in-class medicines that are designed to be selective for cancer cells and non-toxic to normal cells and tissues.
Source: eurekalert.org